Look what i found!
Obviously I have been doing loads of research into cures for cancer. Well look what I found scientific evidence that breast cancer can be destroyed in only 11 days. WOW.
Breast Cancer Destroyed
European scientists have finally discovered a real breakthrough for the most common cancer type in women- breast cancer! It is estimated that one in 8 women will develop this cancer type at some point in her life. However, some hope is given to women as scientists in Amsterdam have given hope; their discovery could save millions of lives.
Breast Cancer Conference
At the European Breast Cancer Conference in Amsterdam, professor Nigel Bundred presented the findings of a recent research which served to evaluate the effects of a couple of drugs, Herceptin (a.k.a trastuzumab) and Lapatinib. These medicaments have been used before but not together for cancer and it is already been deemed to be better than any other treatments like surgery or chemotherapy.
Scientists in Amsterdam have found that mixing Herceptin and Lapatinib together can effectively destroy breast cancer in only 11 days.
Cancer Research UK
The research was funded by the Cancer Research UK, and the goal was to use these two drugs in order to fight against a protein known as HER2 (human epidermal growth factor receptor 2) which is the reason cancer cells divide and develop. Also, there is more chance that this cancer will return than any other cancer.
The best thing about this method is that chemotherapy or surgery don’t have to be used. Also, there are no side effects such as hair loss, fatigue and nausea won’t happen.
We are becoming aware that chemo is far from a beneficial treatment, so this method once fully proven to work is a better and much more beneficial way to treat breast cancer.
A study was done where a group of 257 women where half of the women were a control group that only used Herceptin, and the other group used a combination of both drugs. The results showed that 11% of women who took the combo had no cancer remaining after two weeks. And the other group had 0%, also a 17% of cases featured dramatically shrunken tumours whereas 3% for the other group.
Although the combination of the drugs has extremely beneficial effects in the case of breast cancer, and the effects are shown by using just this drug, the licensing only allows the use of this drug alongside chemotherapy and not just this combination as it stands. However, we are hoping for a change due to these findings.